Infectious diseases are a major global health challenge, causing approximately 17 million deaths each year and placing a massive burden on healthcare systems worldwide.
Rapid and accurate detection of these diseases is critical for effective treatment, containment, and prevention efforts. However, many infectious diseases remain undiagnosed or misdiagnosed, leading to delayed treatment, increased transmission and poor health outcomes.
Covidiag & Covidiag+
Advanced COVID-19 serological analysis tools
Innobiochips has developed the most advanced COVID-19 serological analysis tool based on its proprietary technology: Covidiag.
- Covidiag simultaneously detects and identifies 5 antibodies produced against the SARS-CoV-2 virus, providing highly accurate and reliable results with comprehensive immune profiling.
- The Covidiag+ companion diagnostic solution expands the immune profile performed by detecting antibodies that cross-react with 4 variants (alpha, beta, gamma, delta, omicron).
- The addition of RBD domains from 4 SARS-CoV2 variants allows comparison of antibody response intensities to improve assessment of cross-immunity between different virus strains.